Approximately 40 per cent of cancers in children and teenagers up to the age of 16 are of the haematological variety. A new research programme, launched yesterday (Thurs 5th April) aims to asses how normal gene regulation is subverted in acute leukaemia, with the ultimate goal of developing new and better treatments for every child and adolescent with this blood cancer.
Speaking about the exciting new programme, Dr Jacinta Kelly, Chief Executive of the NCRC, claimed: “this new Chair at UCD will play a pivotal role in the development of a molecular and translational research programme into childhood blood cancers,” said Dr Jacinta Kelly, Chief Executive of the NCRC”.
Professor Owen Smith CBE, Professor of Paediatric and Adolescent Medicine, UCD School of Medicine welcomed Professor Bond to UCD, predicting that he will not be a significant asset to our research activities in paediatric haemato-oncology but will have a major impact in the field of paediatric cancer in Ireland and internationally.
Professor Bond has relocated to Ireland following the completion of a research fellowship at the Hôpital Necker-Enfants Malades, Paris. He completed his undergraduate medical study at Trinity College Dublin and trained as a clinical paediatric haematologist in Ireland and then obtained a PhD in Molecular Haematology at the MRC Clinical Sciences Centre (now the London Institute of Medical Sciences) and Imperial College London.
This programme is a partnership between University College Dublin (UCD), the National Children’s Research Centre (NCRC), and the Children’s Medical and Research Foundation (CMRF) Crumlin today announced the appointment of Jonathan Bond to the newly established Brendan McGonnell UCD Professor of Paediatric Molecular Haemato-Oncology Chair.
Based at the UCD School of Medicine, the new Chair is supported, under the NCRC Research Leadership Award Scheme, by a significant legacy donation from the late Mr Brendan McGonnell to CMRF Crumlin.